Publications by authors named "T Yagisawa"

Introduction: The management of urinary tract stones, particularly kidney allograft stones, presents unique challenges for kidney transplant recipients because of their prevalence and specific clinical considerations. Here, we describe a case in which percutaneous nephrolithotomy was successfully used to fragment a large kidney allograft stone ≥20 mm in size.

Case Presentation: A 57-year-old woman who underwent ureteroureterostomy post simultaneous pancreas-kidney transplantation presented with gross hematuria after 15 years.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the impact of SARS-CoV-2 on kidney transplant (KTx) recipients, highlighting limited data on their treatment and prognosis during the pandemic.
  • Out of 282 KTx patients infected with the virus, 6.7% experienced severe outcomes, with certain underlying health conditions increasing the risk of complications.
  • Treatment strategies evolved over time in response to new variants, with antiviral drugs being administered as they gained approval.
View Article and Find Full Text PDF

The combination therapy of binimetinib, encorafenib, and cetuximab ("triplet regimen") was approved in Japan in November 2020 for the second-line treatment of BRAF V600E mutation-positive colorectal cancer. In this study, we encountered a patient who developed a liver injury requiring drug withdrawal on day eight of the triplet regimen administration. The protocol for the international phase III study did not specify blood and biochemical tests on day eight.

View Article and Find Full Text PDF
Article Synopsis
  • A case report of primary dural lymphoma in a 51-year-old man, who developed it after treatment for subdural empyema, highlighting the link between chronic inflammation and lymphoma.
  • The patient initially presented with symptoms that suggested a chronic subdural hematoma, but further investigation led to the diagnosis of B-cell lymphoma.
  • The case emphasizes the need to consider lymphoma as a possible cause of subdural hematomas when there is no clear underlying pathology.
View Article and Find Full Text PDF